Biocon: Short & Medium term trading plan and idea

Closing Price 628

- The stock is at important levels and we try to analyse different possible scenarios and how one can plan their trade.

- we are looking at 4 possible situations and accordingly one can plan their Trading strategy:-

Situation 1

- In case of dips look to buy in the zone of 618-607 levels for target of 662 / 682 initially.

- pattern gets invalidated if closing is below 600 on weekly closing basis


- In the extreme short term 637-642 may be the deciding level. Trading below the said levels will keep the possibility of dips alive.


On rise those who can take some risk look for selling opportunity in the 635-640 zone with strict SL at 642 and target of 618 / 612 & then
reverse the trade at lower levels to go long


Situation 2

- In case the stock goes higher above the said levels of 637-642 buy with a small ticket size for target of 662 / 682

Situation 3

- the stock continues to rise higher. 696-710 will be an an important defining zone to watch out for. Sustaining above that on weekly closing basis will open up doors for further up movement towards 810 odd levels in medium term. Once it goes above 710 The stock should not come below 677 thereafter.

Scenario 4
The stock falls Below 605. This may turn the counter bearish and may open doors for slide towards 561 / 528 levels. However this could be a tricky situation. There could be chances of false breakdown. So need to be careful on this one. In case of breakdown look for other confirmation points like volume , derivatives insights.

- Safe strategy could be to look to trade the counter after analyzing the behavior on pullbacks. A weaker pullback and inability to cross 620 levels could be ideal situation to go short with minimum SL

- In case the pullback is stronger and conquers 620 odd levels with higher volumes , you know what that would mean...

All the best & safe trading...!!!


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.